2m 2m 2m 2m 2m 2m 2m
WAVE Life Sci (WVE)
NASDAQ
$5.96-$0.21 (-3.48%)
Price as of Jun 23, 2026 4:38 PM EDT- $1.2BMarket Cap
- -11.35%1-Year Change
- BiotechnologyIndustry
WAVE Life Sci (WVE)
$5.96-$0.21 (-3.48%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 42.7M -60.55% | 108.3M -4.42% | 113.3M +3,005.10% | 3.6M -91.09% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 42.7M -60.55% | 108.3M -4.42% | 113.3M +3,005.10% | 3.6M -91.09% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -182.8M +14.46% | -159.7M +22.82% | -130.0M +12.22% | -115.9M -4.94% | |
Depreciation and Amortization Expense | 3.4M -11.70% | 3.9M -22.08% | 5.0M -23.94% | 6.6M -12.15% | |
Total Operating Expenses | 258.1M +18.02% | 218.7M +20.63% | 181.3M +8.98% | 166.4M -0.96% | |
Operating Profit | -215.4M +95.09% | -110.4M +62.37% | -68.0M -58.21% | -162.7M +28.11% | |
Interest Income | 10.5M +3.10% | 10.2M +28.19% | 7.9M +404.65% | 1.6M +5,136.67% | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 10.5M +3.10% | 10.2M +28.19% | 7.9M +404.65% | 1.6M +5,136.67% | |
Total Nonoperating Income and Expense | 11.0M -17.84% | 13.4M +36.60% | 9.8M +521.42% | 1.6M -65.45% | |
Income before Taxes | -204.4M +110.68% | -97.0M +66.71% | -58.2M -63.89% | -161.1M +31.60% | |
Income Taxes | 0 +100.00% | -677,000 0.00% | -677,000 -199.41% | 681,000 +433.82% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -204.4M +110.68% | -97.0M +68.67% | -57.5M -64.46% | -161.8M +32.38% | |
Net Income from Continuing Operations Applicable to Common | -204.4M +110.68% | -97.0M +66.71% | -58.2M -63.89% | -161.1M +31.60% | |
Basic EPS and Net Income | -1.21 +72.86% | -0.70 +29.63% | -0.54 -73.66% | -2.05 -13.14% | |
Diluted EPS and Net Income | -1.21 +72.86% | -0.70 +29.63% | -0.54 -73.66% | -2.05 -13.14% | |
Basic Weighted Average Shares | 168.6M +21.96% | 138.3M +30.33% | 106.1M +34.55% | 78.9M +52.16% | |
Diluted Weighted Average Shares | 168.6M +21.96% | 138.3M +30.33% | 106.1M +34.55% | 78.9M +52.16% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 602.1M +99.31% | 302.1M +50.77% | 200.4M +126.39% | 88.5M -41.22% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 602.1M +99.31% | 302.1M +50.77% | 200.4M +126.39% | 88.5M -41.22% | |
Total Current Assets | 614.8M +91.89% | 320.4M +36.12% | 235.4M +138.87% | 98.5M -39.39% | |
Accumulated Depreciation | 49.5M +6.89% | 46.3M +8.48% | 42.7M +12.85% | 37.8M +17.42% | |
Property and Plant and Equipment and Net | 7.4M -26.89% | 10.1M -22.59% | 13.1M -24.30% | 17.3M -22.37% | |
Total Long-Term Assets | 23.7M -25.55% | 31.8M -19.62% | 39.6M -17.29% | 47.8M +7.66% | |
Total Assets | 638.5M +81.29% | 352.2M +28.10% | 274.9M +87.82% | 146.4M -29.28% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 95.1M -14.32% | 111.0M -40.49% | 186.4M +160.68% | 71.5M +11.40% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 17.2M -27.92% | 23.9M -41.80% | 41.0M -63.42% | 112.1M +9.42% | |
Total Liabilities | 112.3M -16.73% | 134.8M -40.73% | 227.4M +23.88% | 183.6M +10.18% | |
Retained Earnings | -1.3B +18.22% | -1.1B +9.47% | -1.0B +5.95% | -967.3M +20.09% | |
Total Stockholders Equity | 518.4M +147.41% | 209.5M +428.68% | 39.6M +187.89% | -45.1M -238.75% | |
Total Shares Outstanding | 187.7M +22.62% | 153.0M +28.43% | 119.2M +37.09% | 86.9M +45.26% | |
Cash Flow | |||||
Cash from Operating Activities | -187.5M +24.15% | -151.0M +677.24% | -19.4M -84.79% | -127.8M +43.59% | |
Capital Expenditures | 718,000 -23.45% | 938,000 -15.87% | 1.1M -18.07% | 1.4M +143.04% | |
Cash from Investing Activities | -718,000 -23.45% | -938,000 -15.87% | -1.1M -11.16% | -1.3M +124.11% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 488.2M +92.30% | 253.9M +91.57% | 132.5M +97.26% | 67.2M +20.35% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -504.09% +394.50% | -101.94% +69.87% | -60.01% -98.65% | -4,459.30% +1,338.17% | |
Return on Assets | -41.26% +33.37% | -30.94% +13.32% | -27.30% -70.19% | -91.58% +82.14% | |
Return on Equity | -56.16% -27.89% | -77.87% -103.70% | 2,106.32% -18.04% | 2,570.05% +1,311.77% | |
Revenue Growth | -60.55% +1,271.27% | -4.42% -100.15% | 3,005.10% +3,398.96% | -91.09% -187.56% | |
Current Ratio | 6.47 +123.96% | 2.89 +128.73% | 1.26 -8.36% | 1.38 -45.59% | |
Cash Ratio | 6.33 +132.62% | 2.72 +153.36% | 1.07 -13.16% | 1.24 -47.24% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow